Overview

A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain

Status:
Not yet recruiting
Trial end date:
2023-08-07
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy and safety of LY3857210 in participants with Osteoarthritic Pain
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company